THJ-2201
THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB1 receptor.
It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole.
THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB1 receptor.
It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole.
| Price Options | 10g, 20g, 50g, 100g, 500g, 1kg |
|---|